4X6Q
An Isoform-specific Myristylation Switch Targets RIIb PKA Holoenzymes to Membranes
Experimental procedure
Experimental method | SINGLE WAVELENGTH |
Source type | SYNCHROTRON |
Source details | ALS BEAMLINE 8.2.1 |
Synchrotron site | ALS |
Beamline | 8.2.1 |
Temperature [K] | 200 |
Detector technology | CCD |
Collection date | 2013-07-04 |
Detector | ADSC QUANTUM 1 |
Wavelength(s) | 1 |
Spacegroup name | C 2 2 2 |
Unit cell lengths | 152.714, 214.039, 61.872 |
Unit cell angles | 90.00, 90.00, 90.00 |
Refinement procedure
Resolution | 43.821 - 2.520 |
R-factor | 0.2014 |
Rwork | 0.198 |
R-free | 0.26140 |
RMSD bond length | 0.011 |
RMSD bond angle | 1.348 |
Data scaling software | SCALEPACK |
Phasing software | PHASER |
Refinement software | PHENIX ((phenix.refine: 1.9_1692)) |
Data quality characteristics
Overall | |
Low resolution limit [Å] | 44.000 |
High resolution limit [Å] | 2.520 |
Number of reflections | 31571 |
<I/σ(I)> | 24 |
Completeness [%] | 95.3 |
Redundancy | 3 |
Crystallization Conditions
crystal ID | method | pH | temperature | details |
1 | BATCH MODE | 298 | The RIIb(R230K)2: myrC(K7C)2 holoenzyme was concentrated to 12 mg/mL. The crystal used for structure determination was obtained from a 3 uL drop containing 1:1 protein to well solution with the well solution containing 10% PEG8000, 8% ethylene glycol, 20mM MES, at pH5.8. |